Company Filing History:
Years Active: 2007
Title: Shigeru Sassa: Innovator in Therapeutic Delivery Systems
Introduction
Shigeru Sassa is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of therapeutic delivery systems, particularly through his innovative approaches to protein and peptide agents. With a total of 2 patents, Sassa's work is paving the way for advancements in medical treatments.
Latest Patents
Sassa's latest patents focus on methods for delivering potentially therapeutic or prophylactic protein and peptide agents to mammalian cells. These agents are delivered by mutant trypanosomatid protozoa that have been genetically manipulated to code for such protein or peptide agents. Additionally, these mutant protozoa lack certain enzymes within the heme biosynthetic pathway, making them susceptible to porphyria and eventual lysis. Another notable invention discloses the use of a mutant as a suicidal vaccine, wherein the mutant is responsive to external signals to become porphyric and commit suicidal cytolysis. This mutant can be selected from natural species or constructed through genetic engineering.
Career Highlights
Shigeru Sassa is affiliated with Rosalind Franklin University of Medicine and Science, where he continues to advance his research and innovations. His work is characterized by a strong focus on genetic engineering and therapeutic applications.
Collaborations
Sassa collaborates with notable colleagues, including Kwang-Poo Chang and Bala Krishna Kolli, who contribute to his research endeavors.
Conclusion
Shigeru Sassa's innovative work in therapeutic delivery systems exemplifies the potential of genetic engineering in medicine. His contributions are significant in the ongoing quest for effective treatments and vaccines.